news.bostonscientific.com/2025-04-24-Second-phase-of-ADVANTAGE-AF-study-of-FARAPULSE-TM-Pulsed-Field-Ablation-System-meets-primary-safety-and-efficacy-endpoints

Preview meta tags from the news.bostonscientific.com website.

Linked Hostnames

13

Thumbnail

Search Engine Appearance

Google

https://news.bostonscientific.com/2025-04-24-Second-phase-of-ADVANTAGE-AF-study-of-FARAPULSE-TM-Pulsed-Field-Ablation-System-meets-primary-safety-and-efficacy-endpoints

Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints

Study of FARAPULSE pulsed field ablation system achieves positive results in the treatment of persistent atrial fibrillation. Read about the ADVANTAGE trial.



Bing

Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints

https://news.bostonscientific.com/2025-04-24-Second-phase-of-ADVANTAGE-AF-study-of-FARAPULSE-TM-Pulsed-Field-Ablation-System-meets-primary-safety-and-efficacy-endpoints

Study of FARAPULSE pulsed field ablation system achieves positive results in the treatment of persistent atrial fibrillation. Read about the ADVANTAGE trial.



DuckDuckGo

https://news.bostonscientific.com/2025-04-24-Second-phase-of-ADVANTAGE-AF-study-of-FARAPULSE-TM-Pulsed-Field-Ablation-System-meets-primary-safety-and-efficacy-endpoints

Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints

Study of FARAPULSE pulsed field ablation system achieves positive results in the treatment of persistent atrial fibrillation. Read about the ADVANTAGE trial.

  • General Meta Tags

    10
    • title
      Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints
    • Content-Type
      text/html; charset=UTF-8
    • format-detection
      telephone=no
    • X-UA-Compatible
      IE=edge,chrome=1
    • viewport
      width=device-width, initial-scale=1.0

  • Open Graph Meta Tags

    5
    • og:site_name
      Boston Scientific
    • og:url
      https://news.bostonscientific.com/2025-04-24-Second-phase-of-ADVANTAGE-AF-study-of-FARAPULSE-TM-Pulsed-Field-Ablation-System-meets-primary-safety-and-efficacy-endpoints
    • og:title
      Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints
    • og:description
      Trial achieves positive results in the treatment of persistent atrial fibrillation.
    • image
      https://mma.prnewswire.com/media/2671628/Glamour_Shot___Generator_and_Catheter__1.jpg?p=facebook

  • Twitter Meta Tags

    4
    • twitter:card
      summary
    • twitter:title
      Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints
    • twitter:description
      Trial achieves positive results in the treatment of persistent atrial fibrillation.
    • twitter:image
      https://mma.prnewswire.com/media/2671628/Glamour_Shot___Generator_and_Catheter__1.jpg?p=twitter

  • Link Tags

    16
    • alternate
      https://news.bostonscientific.com/news-releases?pagetemplate=rss
    • canonical
      https://news.bostonscientific.com/2025-04-24-Second-phase-of-ADVANTAGE-AF-study-of-FARAPULSE-TM-Pulsed-Field-Ablation-System-meets-primary-safety-and-efficacy-endpoints
    • icon
      ./img/favicon-32x32.png
    • stylesheet
      thirdparty/font-awesome/css/font-awesome.min.css
    • stylesheet
      css/wd_modal.css

  • Website Locales

    1
    • EN_US country flagen_US
      http://www.bostonscientific.com/content/gwc/en-US/about-us.html

Emails

2

Links

189